Automated Insulin Delivery in Type 2 Diabetes

Created using ChatSlide

This case conference focuses on a 66-year-old woman with a 15-year history of type 2 diabetes mellitus (T2DM) and an A1c of 11.1%, despite being on a multidrug regimen including metformin XR, pioglitazone, and dulaglutide, along with insulin glargine. She has no complications and normal kidney function, but also faces comorbid hypertension and hyperlipidemia. The discussion will include insights from the Twist 2D trial, evaluating the benefits and risks of automated insulin delivery systems...